Latest Tenofovir Stories
EDISON, N.J., Jan. 20, 2015 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc.
CORK, Ireland, December 29, 2014 /PRNewswire/ -- -- Two Companies to also Collaborate on the Further Development of Complera(R), Marketed
-- ContraVir to develop CMX157 for multiple antiviral indications -- DURHAM, N.C. and EDISON, N.J., Dec. 18, 2014 /PRNewswire/ -- Chimerix, Inc.
PITTSBURGH and HYDERABAD, India, Dec. 1, 2014 /PRNewswire/ -- Mylan Inc.
December 1st is World AIDS day.
First participant begins testing new technology combining contraception, HIV and herpes prevention ARLINGTON, Va., Nov.
BEERSE, Belgium, September 29, 2014 /PRNewswire/ -- CHMP also issues two label extensions for darunavir Janssen-Cilag International NV (Janssen)
GENEVA, September 25, 2014 /PRNewswire/ -- MPP signs sub-licences with six generic manufacturers for the development of Phase III
MELBOURNE, Australia, July 24, 2014 /PRNewswire/ -- Announced at the 20th International AIDS Conference in Melbourne, the agreement seeks to increase access
Among heterosexual African couples in which the male was HIV positive and the female was not, receipt of antiretroviral pre-exposure preventive (PrEP) therapy did not result in significant differences in pregnancy incidence, birth outcomes, and infant growth compared to females who received placebo.
- totally perplexed and mixed up.